Global Sevoflurane Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Sevoflurane market size is predicted to grow from US$ 1207 million in 2025 to US$ 1506 million in 2031; it is expected to grow at a CAGR of 3.8% from 2025 to 2031.
Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.
The key driver for the Sevoflurane market is the increasing number of surgeries worldwide, driven by the aging population and the rising prevalence of chronic conditions requiring surgical intervention. Sevoflurane is highly preferred due to its rapid onset and recovery, making it ideal for both pediatric and adult patients, particularly in outpatient surgeries. Technological advancements in anesthesia delivery systems and the growing demand for minimally invasive procedures have also contributed to the rising adoption of Sevoflurane in clinical settings. Furthermore, the safety and effectiveness of Sevoflurane in maintaining stable cardiovascular function during anesthesia have enhanced its demand.
One of the main challenges in the Sevoflurane market is its high cost compared to other anesthetic agents, which can limit its accessibility in low- and middle-income regions. Additionally, environmental concerns regarding the use of volatile anesthetics like Sevoflurane, which contribute to greenhouse gas emissions, have led to increased scrutiny and calls for more sustainable alternatives. Regulatory restrictions and the availability of generic alternatives may further impact the market growth, as healthcare providers seek more cost-effective or environmentally friendly options.
LP Information, Inc. (LPI) ' newest research report, the “Sevoflurane Industry Forecast” looks at past sales and reviews total world Sevoflurane sales in 2024, providing a comprehensive analysis by region and market sector of projected Sevoflurane sales for 2025 through 2031. With Sevoflurane sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sevoflurane industry.
This Insight Report provides a comprehensive analysis of the global Sevoflurane landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sevoflurane portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sevoflurane market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sevoflurane and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sevoflurane.
This report presents a comprehensive overview, market shares, and growth opportunities of Sevoflurane market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Sevoflurane market?
What factors are driving Sevoflurane market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Sevoflurane market opportunities vary by end market size?
How does Sevoflurane break out by Type, by Application?
The global Sevoflurane market size is predicted to grow from US$ 1207 million in 2025 to US$ 1506 million in 2031; it is expected to grow at a CAGR of 3.8% from 2025 to 2031.
Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.
The key driver for the Sevoflurane market is the increasing number of surgeries worldwide, driven by the aging population and the rising prevalence of chronic conditions requiring surgical intervention. Sevoflurane is highly preferred due to its rapid onset and recovery, making it ideal for both pediatric and adult patients, particularly in outpatient surgeries. Technological advancements in anesthesia delivery systems and the growing demand for minimally invasive procedures have also contributed to the rising adoption of Sevoflurane in clinical settings. Furthermore, the safety and effectiveness of Sevoflurane in maintaining stable cardiovascular function during anesthesia have enhanced its demand.
One of the main challenges in the Sevoflurane market is its high cost compared to other anesthetic agents, which can limit its accessibility in low- and middle-income regions. Additionally, environmental concerns regarding the use of volatile anesthetics like Sevoflurane, which contribute to greenhouse gas emissions, have led to increased scrutiny and calls for more sustainable alternatives. Regulatory restrictions and the availability of generic alternatives may further impact the market growth, as healthcare providers seek more cost-effective or environmentally friendly options.
LP Information, Inc. (LPI) ' newest research report, the “Sevoflurane Industry Forecast” looks at past sales and reviews total world Sevoflurane sales in 2024, providing a comprehensive analysis by region and market sector of projected Sevoflurane sales for 2025 through 2031. With Sevoflurane sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sevoflurane industry.
This Insight Report provides a comprehensive analysis of the global Sevoflurane landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sevoflurane portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sevoflurane market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sevoflurane and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sevoflurane.
This report presents a comprehensive overview, market shares, and growth opportunities of Sevoflurane market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Generic Drug
- Original Drug
- Hospital
- Clinics
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Hengrui
- Baxter
- Maruishi
- AbbVie
- Piramal
- Viatris
- PT Novell Pharmaceutical
- Lunan Pharma
What is the 10-year outlook for the global Sevoflurane market?
What factors are driving Sevoflurane market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Sevoflurane market opportunities vary by end market size?
How does Sevoflurane break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sevoflurane Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Sevoflurane by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Sevoflurane by Country/Region, 2020, 2024 & 2031
2.2 Sevoflurane Segment by Type
2.2.1 Generic Drug
2.2.2 Original Drug
2.3 Sevoflurane Sales by Type
2.3.1 Global Sevoflurane Sales Market Share by Type (2020-2025)
2.3.2 Global Sevoflurane Revenue and Market Share by Type (2020-2025)
2.3.3 Global Sevoflurane Sale Price by Type (2020-2025)
2.4 Sevoflurane Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Other
2.5 Sevoflurane Sales by Application
2.5.1 Global Sevoflurane Sale Market Share by Application (2020-2025)
2.5.2 Global Sevoflurane Revenue and Market Share by Application (2020-2025)
2.5.3 Global Sevoflurane Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Sevoflurane Breakdown Data by Company
3.1.1 Global Sevoflurane Annual Sales by Company (2020-2025)
3.1.2 Global Sevoflurane Sales Market Share by Company (2020-2025)
3.2 Global Sevoflurane Annual Revenue by Company (2020-2025)
3.2.1 Global Sevoflurane Revenue by Company (2020-2025)
3.2.2 Global Sevoflurane Revenue Market Share by Company (2020-2025)
3.3 Global Sevoflurane Sale Price by Company
3.4 Key Manufacturers Sevoflurane Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sevoflurane Product Location Distribution
3.4.2 Players Sevoflurane Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SEVOFLURANE BY GEOGRAPHIC REGION
4.1 World Historic Sevoflurane Market Size by Geographic Region (2020-2025)
4.1.1 Global Sevoflurane Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Sevoflurane Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Sevoflurane Market Size by Country/Region (2020-2025)
4.2.1 Global Sevoflurane Annual Sales by Country/Region (2020-2025)
4.2.2 Global Sevoflurane Annual Revenue by Country/Region (2020-2025)
4.3 Americas Sevoflurane Sales Growth
4.4 APAC Sevoflurane Sales Growth
4.5 Europe Sevoflurane Sales Growth
4.6 Middle East & Africa Sevoflurane Sales Growth
5 AMERICAS
5.1 Americas Sevoflurane Sales by Country
5.1.1 Americas Sevoflurane Sales by Country (2020-2025)
5.1.2 Americas Sevoflurane Revenue by Country (2020-2025)
5.2 Americas Sevoflurane Sales by Type (2020-2025)
5.3 Americas Sevoflurane Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sevoflurane Sales by Region
6.1.1 APAC Sevoflurane Sales by Region (2020-2025)
6.1.2 APAC Sevoflurane Revenue by Region (2020-2025)
6.2 APAC Sevoflurane Sales by Type (2020-2025)
6.3 APAC Sevoflurane Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Sevoflurane by Country
7.1.1 Europe Sevoflurane Sales by Country (2020-2025)
7.1.2 Europe Sevoflurane Revenue by Country (2020-2025)
7.2 Europe Sevoflurane Sales by Type (2020-2025)
7.3 Europe Sevoflurane Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sevoflurane by Country
8.1.1 Middle East & Africa Sevoflurane Sales by Country (2020-2025)
8.1.2 Middle East & Africa Sevoflurane Revenue by Country (2020-2025)
8.2 Middle East & Africa Sevoflurane Sales by Type (2020-2025)
8.3 Middle East & Africa Sevoflurane Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sevoflurane
10.3 Manufacturing Process Analysis of Sevoflurane
10.4 Industry Chain Structure of Sevoflurane
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sevoflurane Distributors
11.3 Sevoflurane Customer
12 WORLD FORECAST REVIEW FOR SEVOFLURANE BY GEOGRAPHIC REGION
12.1 Global Sevoflurane Market Size Forecast by Region
12.1.1 Global Sevoflurane Forecast by Region (2026-2031)
12.1.2 Global Sevoflurane Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Sevoflurane Forecast by Type (2026-2031)
12.7 Global Sevoflurane Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Hengrui
13.1.1 Hengrui Company Information
13.1.2 Hengrui Sevoflurane Product Portfolios and Specifications
13.1.3 Hengrui Sevoflurane Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Hengrui Main Business Overview
13.1.5 Hengrui Latest Developments
13.2 Baxter
13.2.1 Baxter Company Information
13.2.2 Baxter Sevoflurane Product Portfolios and Specifications
13.2.3 Baxter Sevoflurane Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Baxter Main Business Overview
13.2.5 Baxter Latest Developments
13.3 Maruishi
13.3.1 Maruishi Company Information
13.3.2 Maruishi Sevoflurane Product Portfolios and Specifications
13.3.3 Maruishi Sevoflurane Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Maruishi Main Business Overview
13.3.5 Maruishi Latest Developments
13.4 AbbVie
13.4.1 AbbVie Company Information
13.4.2 AbbVie Sevoflurane Product Portfolios and Specifications
13.4.3 AbbVie Sevoflurane Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 AbbVie Main Business Overview
13.4.5 AbbVie Latest Developments
13.5 Piramal
13.5.1 Piramal Company Information
13.5.2 Piramal Sevoflurane Product Portfolios and Specifications
13.5.3 Piramal Sevoflurane Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Piramal Main Business Overview
13.5.5 Piramal Latest Developments
13.6 Viatris
13.6.1 Viatris Company Information
13.6.2 Viatris Sevoflurane Product Portfolios and Specifications
13.6.3 Viatris Sevoflurane Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Viatris Main Business Overview
13.6.5 Viatris Latest Developments
13.7 PT Novell Pharmaceutical
13.7.1 PT Novell Pharmaceutical Company Information
13.7.2 PT Novell Pharmaceutical Sevoflurane Product Portfolios and Specifications
13.7.3 PT Novell Pharmaceutical Sevoflurane Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 PT Novell Pharmaceutical Main Business Overview
13.7.5 PT Novell Pharmaceutical Latest Developments
13.8 Lunan Pharma
13.8.1 Lunan Pharma Company Information
13.8.2 Lunan Pharma Sevoflurane Product Portfolios and Specifications
13.8.3 Lunan Pharma Sevoflurane Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Lunan Pharma Main Business Overview
13.8.5 Lunan Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sevoflurane Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Sevoflurane by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Sevoflurane by Country/Region, 2020, 2024 & 2031
2.2 Sevoflurane Segment by Type
2.2.1 Generic Drug
2.2.2 Original Drug
2.3 Sevoflurane Sales by Type
2.3.1 Global Sevoflurane Sales Market Share by Type (2020-2025)
2.3.2 Global Sevoflurane Revenue and Market Share by Type (2020-2025)
2.3.3 Global Sevoflurane Sale Price by Type (2020-2025)
2.4 Sevoflurane Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Other
2.5 Sevoflurane Sales by Application
2.5.1 Global Sevoflurane Sale Market Share by Application (2020-2025)
2.5.2 Global Sevoflurane Revenue and Market Share by Application (2020-2025)
2.5.3 Global Sevoflurane Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Sevoflurane Breakdown Data by Company
3.1.1 Global Sevoflurane Annual Sales by Company (2020-2025)
3.1.2 Global Sevoflurane Sales Market Share by Company (2020-2025)
3.2 Global Sevoflurane Annual Revenue by Company (2020-2025)
3.2.1 Global Sevoflurane Revenue by Company (2020-2025)
3.2.2 Global Sevoflurane Revenue Market Share by Company (2020-2025)
3.3 Global Sevoflurane Sale Price by Company
3.4 Key Manufacturers Sevoflurane Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sevoflurane Product Location Distribution
3.4.2 Players Sevoflurane Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SEVOFLURANE BY GEOGRAPHIC REGION
4.1 World Historic Sevoflurane Market Size by Geographic Region (2020-2025)
4.1.1 Global Sevoflurane Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Sevoflurane Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Sevoflurane Market Size by Country/Region (2020-2025)
4.2.1 Global Sevoflurane Annual Sales by Country/Region (2020-2025)
4.2.2 Global Sevoflurane Annual Revenue by Country/Region (2020-2025)
4.3 Americas Sevoflurane Sales Growth
4.4 APAC Sevoflurane Sales Growth
4.5 Europe Sevoflurane Sales Growth
4.6 Middle East & Africa Sevoflurane Sales Growth
5 AMERICAS
5.1 Americas Sevoflurane Sales by Country
5.1.1 Americas Sevoflurane Sales by Country (2020-2025)
5.1.2 Americas Sevoflurane Revenue by Country (2020-2025)
5.2 Americas Sevoflurane Sales by Type (2020-2025)
5.3 Americas Sevoflurane Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sevoflurane Sales by Region
6.1.1 APAC Sevoflurane Sales by Region (2020-2025)
6.1.2 APAC Sevoflurane Revenue by Region (2020-2025)
6.2 APAC Sevoflurane Sales by Type (2020-2025)
6.3 APAC Sevoflurane Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Sevoflurane by Country
7.1.1 Europe Sevoflurane Sales by Country (2020-2025)
7.1.2 Europe Sevoflurane Revenue by Country (2020-2025)
7.2 Europe Sevoflurane Sales by Type (2020-2025)
7.3 Europe Sevoflurane Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sevoflurane by Country
8.1.1 Middle East & Africa Sevoflurane Sales by Country (2020-2025)
8.1.2 Middle East & Africa Sevoflurane Revenue by Country (2020-2025)
8.2 Middle East & Africa Sevoflurane Sales by Type (2020-2025)
8.3 Middle East & Africa Sevoflurane Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sevoflurane
10.3 Manufacturing Process Analysis of Sevoflurane
10.4 Industry Chain Structure of Sevoflurane
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sevoflurane Distributors
11.3 Sevoflurane Customer
12 WORLD FORECAST REVIEW FOR SEVOFLURANE BY GEOGRAPHIC REGION
12.1 Global Sevoflurane Market Size Forecast by Region
12.1.1 Global Sevoflurane Forecast by Region (2026-2031)
12.1.2 Global Sevoflurane Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Sevoflurane Forecast by Type (2026-2031)
12.7 Global Sevoflurane Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Hengrui
13.1.1 Hengrui Company Information
13.1.2 Hengrui Sevoflurane Product Portfolios and Specifications
13.1.3 Hengrui Sevoflurane Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Hengrui Main Business Overview
13.1.5 Hengrui Latest Developments
13.2 Baxter
13.2.1 Baxter Company Information
13.2.2 Baxter Sevoflurane Product Portfolios and Specifications
13.2.3 Baxter Sevoflurane Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Baxter Main Business Overview
13.2.5 Baxter Latest Developments
13.3 Maruishi
13.3.1 Maruishi Company Information
13.3.2 Maruishi Sevoflurane Product Portfolios and Specifications
13.3.3 Maruishi Sevoflurane Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Maruishi Main Business Overview
13.3.5 Maruishi Latest Developments
13.4 AbbVie
13.4.1 AbbVie Company Information
13.4.2 AbbVie Sevoflurane Product Portfolios and Specifications
13.4.3 AbbVie Sevoflurane Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 AbbVie Main Business Overview
13.4.5 AbbVie Latest Developments
13.5 Piramal
13.5.1 Piramal Company Information
13.5.2 Piramal Sevoflurane Product Portfolios and Specifications
13.5.3 Piramal Sevoflurane Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Piramal Main Business Overview
13.5.5 Piramal Latest Developments
13.6 Viatris
13.6.1 Viatris Company Information
13.6.2 Viatris Sevoflurane Product Portfolios and Specifications
13.6.3 Viatris Sevoflurane Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Viatris Main Business Overview
13.6.5 Viatris Latest Developments
13.7 PT Novell Pharmaceutical
13.7.1 PT Novell Pharmaceutical Company Information
13.7.2 PT Novell Pharmaceutical Sevoflurane Product Portfolios and Specifications
13.7.3 PT Novell Pharmaceutical Sevoflurane Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 PT Novell Pharmaceutical Main Business Overview
13.7.5 PT Novell Pharmaceutical Latest Developments
13.8 Lunan Pharma
13.8.1 Lunan Pharma Company Information
13.8.2 Lunan Pharma Sevoflurane Product Portfolios and Specifications
13.8.3 Lunan Pharma Sevoflurane Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Lunan Pharma Main Business Overview
13.8.5 Lunan Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Sevoflurane Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Sevoflurane Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Generic Drug
Table 4. Major Players of Original Drug
Table 5. Global Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 6. Global Sevoflurane Sales Market Share by Type (2020-2025)
Table 7. Global Sevoflurane Revenue by Type (2020-2025) & ($ million)
Table 8. Global Sevoflurane Revenue Market Share by Type (2020-2025)
Table 9. Global Sevoflurane Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global Sevoflurane Sale by Application (2020-2025) & (K Units)
Table 11. Global Sevoflurane Sale Market Share by Application (2020-2025)
Table 12. Global Sevoflurane Revenue by Application (2020-2025) & ($ million)
Table 13. Global Sevoflurane Revenue Market Share by Application (2020-2025)
Table 14. Global Sevoflurane Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Sevoflurane Sales by Company (2020-2025) & (K Units)
Table 16. Global Sevoflurane Sales Market Share by Company (2020-2025)
Table 17. Global Sevoflurane Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Sevoflurane Revenue Market Share by Company (2020-2025)
Table 19. Global Sevoflurane Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Sevoflurane Producing Area Distribution and Sales Area
Table 21. Players Sevoflurane Products Offered
Table 22. Sevoflurane Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Sevoflurane Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Sevoflurane Sales Market Share Geographic Region (2020-2025)
Table 27. Global Sevoflurane Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Sevoflurane Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Sevoflurane Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Sevoflurane Sales Market Share by Country/Region (2020-2025)
Table 31. Global Sevoflurane Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Sevoflurane Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Sevoflurane Sales by Country (2020-2025) & (K Units)
Table 34. Americas Sevoflurane Sales Market Share by Country (2020-2025)
Table 35. Americas Sevoflurane Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 37. Americas Sevoflurane Sales by Application (2020-2025) & (K Units)
Table 38. APAC Sevoflurane Sales by Region (2020-2025) & (K Units)
Table 39. APAC Sevoflurane Sales Market Share by Region (2020-2025)
Table 40. APAC Sevoflurane Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 42. APAC Sevoflurane Sales by Application (2020-2025) & (K Units)
Table 43. Europe Sevoflurane Sales by Country (2020-2025) & (K Units)
Table 44. Europe Sevoflurane Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 46. Europe Sevoflurane Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Sevoflurane Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Sevoflurane Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Sevoflurane Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Sevoflurane
Table 52. Key Market Challenges & Risks of Sevoflurane
Table 53. Key Industry Trends of Sevoflurane
Table 54. Sevoflurane Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Sevoflurane Distributors List
Table 57. Sevoflurane Customer List
Table 58. Global Sevoflurane Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Sevoflurane Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Sevoflurane Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Sevoflurane Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Sevoflurane Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Sevoflurane Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Sevoflurane Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Sevoflurane Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Sevoflurane Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Sevoflurane Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Sevoflurane Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Sevoflurane Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Sevoflurane Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Sevoflurane Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Hengrui Basic Information, Sevoflurane Manufacturing Base, Sales Area and Its Competitors
Table 73. Hengrui Sevoflurane Product Portfolios and Specifications
Table 74. Hengrui Sevoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Hengrui Main Business
Table 76. Hengrui Latest Developments
Table 77. Baxter Basic Information, Sevoflurane Manufacturing Base, Sales Area and Its Competitors
Table 78. Baxter Sevoflurane Product Portfolios and Specifications
Table 79. Baxter Sevoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Baxter Main Business
Table 81. Baxter Latest Developments
Table 82. Maruishi Basic Information, Sevoflurane Manufacturing Base, Sales Area and Its Competitors
Table 83. Maruishi Sevoflurane Product Portfolios and Specifications
Table 84. Maruishi Sevoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Maruishi Main Business
Table 86. Maruishi Latest Developments
Table 87. AbbVie Basic Information, Sevoflurane Manufacturing Base, Sales Area and Its Competitors
Table 88. AbbVie Sevoflurane Product Portfolios and Specifications
Table 89. AbbVie Sevoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. AbbVie Main Business
Table 91. AbbVie Latest Developments
Table 92. Piramal Basic Information, Sevoflurane Manufacturing Base, Sales Area and Its Competitors
Table 93. Piramal Sevoflurane Product Portfolios and Specifications
Table 94. Piramal Sevoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Piramal Main Business
Table 96. Piramal Latest Developments
Table 97. Viatris Basic Information, Sevoflurane Manufacturing Base, Sales Area and Its Competitors
Table 98. Viatris Sevoflurane Product Portfolios and Specifications
Table 99. Viatris Sevoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Viatris Main Business
Table 101. Viatris Latest Developments
Table 102. PT Novell Pharmaceutical Basic Information, Sevoflurane Manufacturing Base, Sales Area and Its Competitors
Table 103. PT Novell Pharmaceutical Sevoflurane Product Portfolios and Specifications
Table 104. PT Novell Pharmaceutical Sevoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. PT Novell Pharmaceutical Main Business
Table 106. PT Novell Pharmaceutical Latest Developments
Table 107. Lunan Pharma Basic Information, Sevoflurane Manufacturing Base, Sales Area and Its Competitors
Table 108. Lunan Pharma Sevoflurane Product Portfolios and Specifications
Table 109. Lunan Pharma Sevoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Lunan Pharma Main Business
Table 111. Lunan Pharma Latest Developments
Table 1. Sevoflurane Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Sevoflurane Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Generic Drug
Table 4. Major Players of Original Drug
Table 5. Global Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 6. Global Sevoflurane Sales Market Share by Type (2020-2025)
Table 7. Global Sevoflurane Revenue by Type (2020-2025) & ($ million)
Table 8. Global Sevoflurane Revenue Market Share by Type (2020-2025)
Table 9. Global Sevoflurane Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global Sevoflurane Sale by Application (2020-2025) & (K Units)
Table 11. Global Sevoflurane Sale Market Share by Application (2020-2025)
Table 12. Global Sevoflurane Revenue by Application (2020-2025) & ($ million)
Table 13. Global Sevoflurane Revenue Market Share by Application (2020-2025)
Table 14. Global Sevoflurane Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Sevoflurane Sales by Company (2020-2025) & (K Units)
Table 16. Global Sevoflurane Sales Market Share by Company (2020-2025)
Table 17. Global Sevoflurane Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Sevoflurane Revenue Market Share by Company (2020-2025)
Table 19. Global Sevoflurane Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Sevoflurane Producing Area Distribution and Sales Area
Table 21. Players Sevoflurane Products Offered
Table 22. Sevoflurane Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Sevoflurane Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Sevoflurane Sales Market Share Geographic Region (2020-2025)
Table 27. Global Sevoflurane Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Sevoflurane Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Sevoflurane Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Sevoflurane Sales Market Share by Country/Region (2020-2025)
Table 31. Global Sevoflurane Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Sevoflurane Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Sevoflurane Sales by Country (2020-2025) & (K Units)
Table 34. Americas Sevoflurane Sales Market Share by Country (2020-2025)
Table 35. Americas Sevoflurane Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 37. Americas Sevoflurane Sales by Application (2020-2025) & (K Units)
Table 38. APAC Sevoflurane Sales by Region (2020-2025) & (K Units)
Table 39. APAC Sevoflurane Sales Market Share by Region (2020-2025)
Table 40. APAC Sevoflurane Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 42. APAC Sevoflurane Sales by Application (2020-2025) & (K Units)
Table 43. Europe Sevoflurane Sales by Country (2020-2025) & (K Units)
Table 44. Europe Sevoflurane Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 46. Europe Sevoflurane Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Sevoflurane Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Sevoflurane Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Sevoflurane Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Sevoflurane Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Sevoflurane
Table 52. Key Market Challenges & Risks of Sevoflurane
Table 53. Key Industry Trends of Sevoflurane
Table 54. Sevoflurane Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Sevoflurane Distributors List
Table 57. Sevoflurane Customer List
Table 58. Global Sevoflurane Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Sevoflurane Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Sevoflurane Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Sevoflurane Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Sevoflurane Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Sevoflurane Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Sevoflurane Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Sevoflurane Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Sevoflurane Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Sevoflurane Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Sevoflurane Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Sevoflurane Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Sevoflurane Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Sevoflurane Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Hengrui Basic Information, Sevoflurane Manufacturing Base, Sales Area and Its Competitors
Table 73. Hengrui Sevoflurane Product Portfolios and Specifications
Table 74. Hengrui Sevoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Hengrui Main Business
Table 76. Hengrui Latest Developments
Table 77. Baxter Basic Information, Sevoflurane Manufacturing Base, Sales Area and Its Competitors
Table 78. Baxter Sevoflurane Product Portfolios and Specifications
Table 79. Baxter Sevoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Baxter Main Business
Table 81. Baxter Latest Developments
Table 82. Maruishi Basic Information, Sevoflurane Manufacturing Base, Sales Area and Its Competitors
Table 83. Maruishi Sevoflurane Product Portfolios and Specifications
Table 84. Maruishi Sevoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Maruishi Main Business
Table 86. Maruishi Latest Developments
Table 87. AbbVie Basic Information, Sevoflurane Manufacturing Base, Sales Area and Its Competitors
Table 88. AbbVie Sevoflurane Product Portfolios and Specifications
Table 89. AbbVie Sevoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. AbbVie Main Business
Table 91. AbbVie Latest Developments
Table 92. Piramal Basic Information, Sevoflurane Manufacturing Base, Sales Area and Its Competitors
Table 93. Piramal Sevoflurane Product Portfolios and Specifications
Table 94. Piramal Sevoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Piramal Main Business
Table 96. Piramal Latest Developments
Table 97. Viatris Basic Information, Sevoflurane Manufacturing Base, Sales Area and Its Competitors
Table 98. Viatris Sevoflurane Product Portfolios and Specifications
Table 99. Viatris Sevoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Viatris Main Business
Table 101. Viatris Latest Developments
Table 102. PT Novell Pharmaceutical Basic Information, Sevoflurane Manufacturing Base, Sales Area and Its Competitors
Table 103. PT Novell Pharmaceutical Sevoflurane Product Portfolios and Specifications
Table 104. PT Novell Pharmaceutical Sevoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. PT Novell Pharmaceutical Main Business
Table 106. PT Novell Pharmaceutical Latest Developments
Table 107. Lunan Pharma Basic Information, Sevoflurane Manufacturing Base, Sales Area and Its Competitors
Table 108. Lunan Pharma Sevoflurane Product Portfolios and Specifications
Table 109. Lunan Pharma Sevoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Lunan Pharma Main Business
Table 111. Lunan Pharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Sevoflurane
Figure 2. Sevoflurane Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sevoflurane Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Sevoflurane Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Sevoflurane Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Sevoflurane Sales Market Share by Country/Region (2024)
Figure 10. Sevoflurane Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Generic Drug
Figure 12. Product Picture of Original Drug
Figure 13. Global Sevoflurane Sales Market Share by Type in 2025
Figure 14. Global Sevoflurane Revenue Market Share by Type (2020-2025)
Figure 15. Sevoflurane Consumed in Hospital
Figure 16. Global Sevoflurane Market: Hospital (2020-2025) & (K Units)
Figure 17. Sevoflurane Consumed in Clinics
Figure 18. Global Sevoflurane Market: Clinics (2020-2025) & (K Units)
Figure 19. Sevoflurane Consumed in Other
Figure 20. Global Sevoflurane Market: Other (2020-2025) & (K Units)
Figure 21. Global Sevoflurane Sale Market Share by Application (2024)
Figure 22. Global Sevoflurane Revenue Market Share by Application in 2025
Figure 23. Sevoflurane Sales by Company in 2025 (K Units)
Figure 24. Global Sevoflurane Sales Market Share by Company in 2025
Figure 25. Sevoflurane Revenue by Company in 2025 ($ millions)
Figure 26. Global Sevoflurane Revenue Market Share by Company in 2025
Figure 27. Global Sevoflurane Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Sevoflurane Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Sevoflurane Sales 2020-2025 (K Units)
Figure 30. Americas Sevoflurane Revenue 2020-2025 ($ millions)
Figure 31. APAC Sevoflurane Sales 2020-2025 (K Units)
Figure 32. APAC Sevoflurane Revenue 2020-2025 ($ millions)
Figure 33. Europe Sevoflurane Sales 2020-2025 (K Units)
Figure 34. Europe Sevoflurane Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Sevoflurane Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Sevoflurane Revenue 2020-2025 ($ millions)
Figure 37. Americas Sevoflurane Sales Market Share by Country in 2025
Figure 38. Americas Sevoflurane Revenue Market Share by Country (2020-2025)
Figure 39. Americas Sevoflurane Sales Market Share by Type (2020-2025)
Figure 40. Americas Sevoflurane Sales Market Share by Application (2020-2025)
Figure 41. United States Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Sevoflurane Sales Market Share by Region in 2025
Figure 46. APAC Sevoflurane Revenue Market Share by Region (2020-2025)
Figure 47. APAC Sevoflurane Sales Market Share by Type (2020-2025)
Figure 48. APAC Sevoflurane Sales Market Share by Application (2020-2025)
Figure 49. China Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 53. India Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Sevoflurane Sales Market Share by Country in 2025
Figure 57. Europe Sevoflurane Revenue Market Share by Country (2020-2025)
Figure 58. Europe Sevoflurane Sales Market Share by Type (2020-2025)
Figure 59. Europe Sevoflurane Sales Market Share by Application (2020-2025)
Figure 60. Germany Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 61. France Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Sevoflurane Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Sevoflurane Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Sevoflurane Sales Market Share by Application (2020-2025)
Figure 68. Egypt Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Sevoflurane in 2025
Figure 74. Manufacturing Process Analysis of Sevoflurane
Figure 75. Industry Chain Structure of Sevoflurane
Figure 76. Channels of Distribution
Figure 77. Global Sevoflurane Sales Market Forecast by Region (2026-2031)
Figure 78. Global Sevoflurane Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Sevoflurane Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Sevoflurane Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Sevoflurane Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Sevoflurane Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Sevoflurane
Figure 2. Sevoflurane Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sevoflurane Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Sevoflurane Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Sevoflurane Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Sevoflurane Sales Market Share by Country/Region (2024)
Figure 10. Sevoflurane Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Generic Drug
Figure 12. Product Picture of Original Drug
Figure 13. Global Sevoflurane Sales Market Share by Type in 2025
Figure 14. Global Sevoflurane Revenue Market Share by Type (2020-2025)
Figure 15. Sevoflurane Consumed in Hospital
Figure 16. Global Sevoflurane Market: Hospital (2020-2025) & (K Units)
Figure 17. Sevoflurane Consumed in Clinics
Figure 18. Global Sevoflurane Market: Clinics (2020-2025) & (K Units)
Figure 19. Sevoflurane Consumed in Other
Figure 20. Global Sevoflurane Market: Other (2020-2025) & (K Units)
Figure 21. Global Sevoflurane Sale Market Share by Application (2024)
Figure 22. Global Sevoflurane Revenue Market Share by Application in 2025
Figure 23. Sevoflurane Sales by Company in 2025 (K Units)
Figure 24. Global Sevoflurane Sales Market Share by Company in 2025
Figure 25. Sevoflurane Revenue by Company in 2025 ($ millions)
Figure 26. Global Sevoflurane Revenue Market Share by Company in 2025
Figure 27. Global Sevoflurane Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Sevoflurane Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Sevoflurane Sales 2020-2025 (K Units)
Figure 30. Americas Sevoflurane Revenue 2020-2025 ($ millions)
Figure 31. APAC Sevoflurane Sales 2020-2025 (K Units)
Figure 32. APAC Sevoflurane Revenue 2020-2025 ($ millions)
Figure 33. Europe Sevoflurane Sales 2020-2025 (K Units)
Figure 34. Europe Sevoflurane Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Sevoflurane Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Sevoflurane Revenue 2020-2025 ($ millions)
Figure 37. Americas Sevoflurane Sales Market Share by Country in 2025
Figure 38. Americas Sevoflurane Revenue Market Share by Country (2020-2025)
Figure 39. Americas Sevoflurane Sales Market Share by Type (2020-2025)
Figure 40. Americas Sevoflurane Sales Market Share by Application (2020-2025)
Figure 41. United States Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Sevoflurane Sales Market Share by Region in 2025
Figure 46. APAC Sevoflurane Revenue Market Share by Region (2020-2025)
Figure 47. APAC Sevoflurane Sales Market Share by Type (2020-2025)
Figure 48. APAC Sevoflurane Sales Market Share by Application (2020-2025)
Figure 49. China Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 53. India Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Sevoflurane Sales Market Share by Country in 2025
Figure 57. Europe Sevoflurane Revenue Market Share by Country (2020-2025)
Figure 58. Europe Sevoflurane Sales Market Share by Type (2020-2025)
Figure 59. Europe Sevoflurane Sales Market Share by Application (2020-2025)
Figure 60. Germany Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 61. France Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Sevoflurane Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Sevoflurane Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Sevoflurane Sales Market Share by Application (2020-2025)
Figure 68. Egypt Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Sevoflurane Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Sevoflurane in 2025
Figure 74. Manufacturing Process Analysis of Sevoflurane
Figure 75. Industry Chain Structure of Sevoflurane
Figure 76. Channels of Distribution
Figure 77. Global Sevoflurane Sales Market Forecast by Region (2026-2031)
Figure 78. Global Sevoflurane Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Sevoflurane Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Sevoflurane Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Sevoflurane Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Sevoflurane Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Aloesin Market Growth 2025-2031
US$ 3,660.00
January 2025
80 pages
Global Food Grade Gases Market Growth 2025-2031
US$ 3,660.00
September 2025
123 pages
Global Butanediol Market Growth 2025-2031
US$ 3,660.00
October 2025
81 pages
